RF Industries Appoints Seasoned Financial Executive Mark Holdsworth to Board of Directors
SAN DIEGO, CA / ACCESSWIRE / January 5, 2021 / RF Industries, Ltd. (NASDAQ:RFIL), a…
SAN DIEGO, CA / ACCESSWIRE / January 5, 2021 / RF Industries, Ltd. (NASDAQ:RFIL), a…
NORTHVALE, NJ / ACCESSWIRE / January 5, 2021 / Elite Pharmaceuticals, Inc. (“Elite” or the…
VANCOUVER, BC / ACCESSWIRE / January 5, 2021 / Snipp Interactive Inc. (“Snipp”, the “Company”)…
Affordable Medical-Grade Nitrile Exam Gloves to Be Distributed to US Market During 2021 Q1 NEW…
MONTREAL, QC / ACCESSWIRE / January 5, 2021 / Amex Exploration Inc. (“Amex or the…
TORONTO, ON / ACCESSWIRE / January 5, 2021 / Roscan Gold Corporation (“Roscan” or the “Company”)…
LOS ANGELES, CA / ACCESSWIRE / January 5, 2021 / You probably read a lot…
“Establishing a sustainable recycling system… Improving the local community environment and helping residents to become…
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN…
The COVID-19 Pandemic has interestingly led to an uptick in the use and interest in…
Funds advised by Hilltop Credit Partners Limited (“Hilltop”) have provided a development finance facility of…
PRESS RELEASE Emergex Vaccines signs Collaboration Agreement with Brazil’s Bio-Manguinhos/Fiocruz for the Development of a…
ALLSCHWIL, Switzerland, Jan. 05, 2021 (GLOBE NEWSWIRE) — Polyphor AG (SIX: POLN) announced today that…
LONDON and RALEIGH, N.C., Jan. 05, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…
Collaboration with Biogen to develop gene therapy for an undisclosed target to treat inherited eye…
IPH6101/SAR443579 is an NKp46-based NK cell engager (NKCE) that uses Innate’s proprietary multispecific antibody format…
Press Release Nicox Highlights Successful 2020 Development Progress and Clinical Milestones for 2021 Initiated…
COPENHAGEN, Denmark, January 5, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today…
Investors can pre-register for the event here LAUSANNE, Switzerland, Jan. 05, 2021 (GLOBE NEWSWIRE) —…
Tiragolumab is the first anti-TIGIT therapy to be granted Breakthrough Therapy Designation (BTD) and marks…